Statins in patients with sepsis and ARDS: is it over? Yes

Intensive Care Med. 2017 May;43(5):672-674. doi: 10.1007/s00134-016-4585-z. Epub 2016 Oct 17.

Authors

Waleed Alhazzani^{1

2}, Jonathon Truwit³

Affiliations

¹ Department of Medicine, Division of Critical Care, McMaster University, Hamilton, Canada.
² Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada.
³ Department of Medicine, Pulmonary and Critical Care, Froedtert and Medical College of Wisconsin, Milwaukee, USA. truwit@froedtert.com.

PMID: 27752735
DOI: 10.1007/s00134-016-4585-z

No abstract available

Publication types

Editorial

MeSH terms

Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Observational Studies as Topic
Outcome Assessment, Health Care
Randomized Controlled Trials as Topic
Respiratory Distress Syndrome / drug therapy*
Respiratory Distress Syndrome / etiology
Respiratory Distress Syndrome / mortality
Sepsis / complications
Sepsis / drug therapy*
Sepsis / mortality

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors